Abstract
Background:Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive therapies have attenuated humoral vaccine responses and are prone to more severe infections. Assessing the persistence of cellular and humoral immunity following...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have